| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |